1. Home
  2. SPOK vs TECX Comparison

SPOK vs TECX Comparison

Compare SPOK & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPOK
  • TECX
  • Stock Information
  • Founded
  • SPOK 2004
  • TECX 2019
  • Country
  • SPOK United States
  • TECX United States
  • Employees
  • SPOK N/A
  • TECX N/A
  • Industry
  • SPOK Telecommunications Equipment
  • TECX
  • Sector
  • SPOK Telecommunications
  • TECX
  • Exchange
  • SPOK Nasdaq
  • TECX Nasdaq
  • Market Cap
  • SPOK 379.1M
  • TECX 387.1M
  • IPO Year
  • SPOK 1992
  • TECX 2018
  • Fundamental
  • Price
  • SPOK $17.33
  • TECX $16.78
  • Analyst Decision
  • SPOK Hold
  • TECX Buy
  • Analyst Count
  • SPOK 1
  • TECX 6
  • Target Price
  • SPOK $15.00
  • TECX $79.17
  • AVG Volume (30 Days)
  • SPOK 157.6K
  • TECX 443.3K
  • Earning Date
  • SPOK 10-29-2025
  • TECX 11-06-2025
  • Dividend Yield
  • SPOK 7.17%
  • TECX N/A
  • EPS Growth
  • SPOK 10.71
  • TECX N/A
  • EPS
  • SPOK 0.83
  • TECX N/A
  • Revenue
  • SPOK $140,742,000.00
  • TECX N/A
  • Revenue This Year
  • SPOK $2.26
  • TECX N/A
  • Revenue Next Year
  • SPOK $3.69
  • TECX N/A
  • P/E Ratio
  • SPOK $21.00
  • TECX N/A
  • Revenue Growth
  • SPOK 1.79
  • TECX N/A
  • 52 Week Low
  • SPOK $13.55
  • TECX $13.70
  • 52 Week High
  • SPOK $19.31
  • TECX $61.07
  • Technical
  • Relative Strength Index (RSI)
  • SPOK 38.51
  • TECX 33.41
  • Support Level
  • SPOK $17.96
  • TECX $15.34
  • Resistance Level
  • SPOK $18.23
  • TECX $18.61
  • Average True Range (ATR)
  • SPOK 0.36
  • TECX 1.65
  • MACD
  • SPOK -0.08
  • TECX -1.05
  • Stochastic Oscillator
  • SPOK 17.35
  • TECX 11.26

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: